BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/7/2015 6:08:00 PM | Browse: 1244 | Download: 2317
 |
Received |
|
2014-09-03 17:45 |
|
Peer-Review Started |
|
2014-09-04 16:19 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-10-10 08:35 |
|
Revised |
|
2014-11-07 23:36 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-12-08 14:44 |
|
Second Decision by Editor-in-Chief |
|
2014-12-10 09:52 |
|
Final Decision by Editorial Office Director |
|
2014-12-16 10:16 |
|
Articles in Press |
|
2014-12-16 10:42 |
|
Edit the Manuscript by Language Editor |
|
2014-12-30 09:06 |
|
Typeset the Manuscript |
|
2015-03-24 15:58 |
|
Publish the Manuscript Online |
|
2015-04-07 17:13 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chih-Chi Kuo, Yu-Lueng Shih, Her-Young Su, Ming-De Yan, Chung-Bao Hsieh, Chin-Yu Liu, Wei-Ting Huang, Mu-Hsien Yu and Ya-Wen Lin |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Science Council, Taiwan |
NSC 102-2320-B-016-016-MY3 |
| Liver Disease Prevention and Treatment Research Foundation, Taiwan |
|
|
| Corresponding Author |
Ya-Wen Lin, PhD, Department and Graduate Institute of Microbiology and Immunology, Graduate Institute of Medical Sciences, National Defense Medical Center, No. 161, Section 6, Min-Chuan East Road, Taipei 114, Taiwan. ndmc.yawen@msa.hinet.net |
| Key Words |
IRAK3; GLOXD1; Hepatocellular carcinoma; DNA methylation biomarker; Quantitative methylation-specific polymerase chain reaction; Pyrosequencing |
| Core Tip |
The methylation biomarker is relatively stable in tissue samples and body fluids, suggesting that it is a good tool for the detection, diagnosis, prognosis, and even therapy of hepatocellular carcinoma (HCC). Our study not only demonstrated frequent methylation of interleukin-1 receptor-associated kinase 3 (IRAK3) and GLOXD1 in HCC but also found that IRAK3 methylation was positively associated with poor 3-year disease-free survival of patients. This indicates that IRAK3 methylation could be used as a potential biomarker for prediction of prognosis in HCC. |
| Publish Date |
2015-04-07 17:13 |
| Citation |
Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3960-3969 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i13/3960.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i13.3960 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
